| Revenue | SEK 0 | — |
| EBITDA | SEK -7K | +67% |
| Net profit | SEK -6K | +73% |
| Total assets | SEK 335K | +1% |
| Equity | SEK 285K | -2% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | — | 154 | 27 | 6 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | −15 | −124 | 6 | −32 | −23 | −21 | −7 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −15 | −124 | 6 | −32 | −23 | −21 | −7 |
| Net financials | — | — | — | — | — | −1 | — |
| Profit before tax | −15 | −124 | 6 | −32 | −23 | −22 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −15 | −124 | 6 | −32 | −23 | −22 | −6 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 582 | 470 | 384 | 356 | 333 | 331 | 335 |
| Equity | 486 | 361 | 367 | 336 | 313 | 291 | 285 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 96 | 108 | 17 | 20 | 20 | 40 | 50 |
| Total debt | 96 | 108 | 17 | 20 | 20 | 40 | 50 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Centigo AB | Company | 100.0% | 100.0% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Audit | 0 companies |
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |